Cargando…

Lipid nanoparticles for cyclosporine A administration: development, characterization, and in vitro evaluation of their immunosuppression activity

Cyclosporine A (CsA) is an immunosuppressant commonly used in transplantation for prevention of organ rejection as well as in the treatment of several autoimmune disorders. Although commercial formulations are available, they have some stability, bioavailability, and toxicity related problems. Some...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guada, Melissa, Sebastián, Victor, Irusta, Silvia, Feijoó, Esperanza, Dios-Viéitez, María del Carmen, Blanco-Prieto, María José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621240/ https://www.ncbi.nlm.nih.gov/pubmed/26527872 http://dx.doi.org/10.2147/IJN.S90849

Ejemplares similares

Development and Validation of a HPLC Method for the Determination of Cyclosporine A in New Bioadhesive Nanoparticles for Oral Administration
por: Pecchio, M., et al.
Publicado: (2014)

Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A
por: Tang, Li, et al.
Publicado: (2012)

Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method
por: Urbán-Morlán, Zaida, et al.
Publicado: (2010)

Development of ulcerative colitis under the immunosuppressive effect of cyclosporine
por: Passfall, J., et al.
Publicado: (1992)

Microfluidic Synthesis and Biological Evaluation of Photothermal Biodegradable Copper Sulfide Nanoparticles
por: Ortiz de Solorzano, Isabel, et al.
Publicado: (2016)

Improved Dermal Delivery of Cyclosporine A Loaded in Solid Lipid Nanoparticles
por: Essaghraoui, Abderrazzaq, et al.
Publicado: (2019)

Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A?
Publicado: (1991)

Freeze-Dried Softisan(®) 649-Based Lipid Nanoparticles for Enhanced Skin Delivery of Cyclosporine A
por: Silva, Maria Inês, et al.
Publicado: (2020)

Microflow Nanoprecipitation of Positively Charged Gastroresistant Polymer Nanoparticles of Eudragit(®) RS100: A Study of Fluid Dynamics and Chemical Parameters
por: Yus, Cristina, et al.
Publicado: (2020)

Evaluation of biochemical and reproductive biomarkers on gestational period in immunosuppressed Wistar rats with Cyclosporin
por: Schavinski, Aline Zanatta, et al.
Publicado: (2015)

Is the Antiproteinuric Effect of Cyclosporine A Independent of Its Immunosuppressive Function in T Cells?
por: Zhang, Bin, et al.
Publicado: (2012)

Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
por: Scioli Montoto, Sebastián, et al.
Publicado: (2020)

Immunosuppressive calcineurin inhibitor cyclosporine A induces proapoptotic endoplasmic reticulum stress in renal tubular cells
por: Yilmaz, Duygu Elif, et al.
Publicado: (2022)

Cyclosporine-A-Based Immunosuppressive Therapy-Induced Neurotoxicity: A Case Report
por: Teimouri, Ali, et al.
Publicado: (2020)

Solid Lipid Nanoparticles of Mycophenolate Mofetil: An Attempt to Control the Release of an Immunosuppressant
por: Iqbal, Asma, et al.
Publicado: (2020)

Viscosified Solid Lipidic Nanoparticles Based on Naringenin and Linolenic Acid for the Release of Cyclosporine A on the Skin
por: Trombino, Sonia, et al.
Publicado: (2020)

Effect of Tacrolimus and Cyclosporine Immunosuppressants on Peripheral Nerve Regeneration: Systematic Review and Meta-analysis
por: Seixas, Stéphanie Farias, et al.
Publicado: (2022)

Differential Effects of X-Irradiation and Cyclosporin-A Administration on the Thymus with Respect to the Generation of Cyclosporin-A-Induced Autoimmunity
por: Beijleveld, Leo J.J., et al.
Publicado: (1995)

The time of administration of immunosuppressives.
por: Knapp, M. S.
Publicado: (1981)

Preparation and in vitro and in vivo characterization of cyclosporin A-loaded, PEGylated chitosan-modified, lipid-based nanoparticles
por: Zhang, Ling, et al.
Publicado: (2013)

Effects of immunosuppressants, FK506 and cyclosporin A, on the osteogenic differentiation of rat mesenchymal stem cells
por: Byun, Yu-Kyung, et al.
Publicado: (2012)

Budget impact analysis of conversion from cyclosporine to sirolimus as immunosuppressive medication in renal transplantation therapy
por: Foroutan, Naghmeh, et al.
Publicado: (2013)

Differential Glycosylation Expression in Injured Rat Spinal Cord Treated with Immunosuppressive Drug Cyclosporin-A
por: Kilcoyne, Michelle, et al.
Publicado: (2019)

Evaluation of in vitro antileishmanial efficacy of cyclosporin A and its non-immunosuppressive derivative, dihydrocyclosporin A
por: Zheng, Zhi-Wan, et al.
Publicado: (2020)

Treatment with the calcineurin inhibitor and immunosuppressant cyclosporine A impairs sensorimotor gating in Dark Agouti rats
por: Brosda, Jan, et al.
Publicado: (2020)

Effects Following Intracerebroventricular Injection of Immunosuppressant Cyclosporine A On Inhibitory Avoidance Learning and Memory in Mice
por: Banafshe, Hamid Reza, et al.
Publicado: (2018)

Avocado Seeds Relieve Oxidative Stress-Dependent Nephrotoxicity but Enhance Immunosuppression Induced by Cyclosporine in Rats
por: Elmoslemany, Amira M., et al.
Publicado: (2021)

Differential effects of the immunosuppressive calcineurin inhibitors cyclosporine-A and tacrolimus on ovulation in a murine model
por: Zakerkish, F, et al.
Publicado: (2021)

New Nanoparticle Formulation for Cyclosporin A: In Vitro Assessment
por: Gendron, Amandine, et al.
Publicado: (2021)

Effects of cyclosporin A and a non-immunosuppressive analogue, O-acetyl cyclosporin A, upon the growth of parent and multidrug resistant human lung cancer cells in vitro.
por: Twentyman, P. R., et al.
Publicado: (1992)

Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
por: Hassett, Kimberly J., et al.
Publicado: (2019)

The Tumorigenicity of Multipotent Adult Germline Stem Cells Transplanted into the Heart Is Affected by Natural Killer Cells and by Cyclosporine A Independent of Its Immunosuppressive Effects
por: Hübscher, Daniela, et al.
Publicado: (2017)

Decoration of Squalenoyl‐Gemcitabine Nanoparticles with Squalenyl‐Hydroxybisphosphonate for the Treatment of Bone Tumors
por: Rodríguez‐Nogales, Carlos, et al.
Publicado: (2021)

Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives.
por: GavÃ©riaux, C., et al.
Publicado: (1989)

Biliary diseases in heart transplanted patients: a comparison between cyclosporine a versus tacrolimus-based immunosuppression
por: Stief, J, et al.
Publicado: (2009)

Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation
por: Helmschrott, Matthias, et al.
Publicado: (2015)

Immunological benefits by ginseng through reciprocal regulation of Th17 and Treg cells during cyclosporine-induced immunosuppression
por: Heo, Seong Beom, et al.
Publicado: (2016)

Successful Triple Combination Immunosuppressive Therapy with Prednisolone, Cyclosporine, and Mycophenolate Mofetil to Treat Recurrent Giant Cell Myocarditis
por: Akita, Tomomi, et al.
Publicado: (2019)

Immunosuppression Agent Cyclosporine Reduces Self‐Renewal and Vessel Regeneration Potentiation of Human Endothelial Colony Forming Cells
por: Sim, Seen‐Ling, et al.
Publicado: (2018)

S184: SAFETY AND OUTCOMES FOLLOWING IMMUNOSUPPRESSIVE THERAPY WITH ATG/CYCLOSPORIN +/- ELTROMBOPAG FOR OLDER PATIENTS WITH SEVERE APLASTIC ANEMIA
por: Prabahran, Ashvind, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p16u2feshb08j2lpsun1rqbfui